Literature DB >> 11561756

The role of histological investigation in prognostic evaluation of advanced gastric cancer. Analysis of histological structure and molecular changes compared with invasive pattern and stage.

A M Chiaravalli1, M Cornaggia, D Furlan, C Capella, R Fiocca, G Tagliabue, C Klersy, E Solcia.   

Abstract

The relative contribution of tumour histology or molecular changes, compared with invasion pattern or stage, to prognostic assessment of gastric cancer was investigated in a series of 185 advanced (T2 to T4, stage IB to IV) cancers that had undergone intentionally curative surgery at Varese General Hospital. Survival analysis of the histological types considered in commonly used classifications, such as Lauren, Kubo, the World Health Organization (WHO) and related classifications, allowed separation of a small high-grade (Hg, 12 cases) group of adenosquamous, anaplastic and small cell endocrine carcinomas from a large cohesive group (C, 86 glandular or solid cancers) and from another large (87 cases) group of tumours with dissociated cells [29 diffuse (D) and 58 mixed (M) tumours]. Univariate and multivariate analysis showed the independent prognostic value of this C/M+D/Hg classification approach, which proved superior to other classifications and to cell dissociation at the growing front or angio, lympho and neuro-invasion. Expression of sialyl Lewis(c), the DUPAN-2 antigen, proved to be an independent predictor of worse survival among tumours beyond stage I, showing an exclusively or predominantly cohesive structure. Microsatellite instability (MSI) predicted favourable survival in purely cohesive tumours of intermediate (II) stage, especially of solid/medullary and lymphoid stroma/lympho-epithelioma-like structure, among which two distinct tumour subsets were characterised, one MSI-positive and the other Epstein-Barr virus positive. T2NOM0 (stage IB) tumours showed mostly favourable survival independently from histological type, invasive pattern, DUPAN-2 or MSI status. It is concluded that an appropriate histological evaluation, coupled with sialylated glycoproteins histochemistry and, for stage-II tumours, MSI tests may contribute significantly to prognostic assessment of tumours beyond stage I. However, the stage itself, with special reference to lymph-node metastases and invasion level beyond subserosa, remains the most important prognostic clue for gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561756     DOI: 10.1007/s004280100441

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  24 in total

1.  Histotype-based prognostic classification of gastric cancer.

Authors:  Anna Maria Chiaravalli; Catherine Klersy; Alessandro Vanoli; Andrea Ferretti; Carlo Capella; Enrico Solcia
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation.

Authors:  Olga Speck; Weihua Tang; Douglas R Morgan; Pei Fen Kuan; Michael O Meyers; Ricardo L Dominguez; Enrique Martinez; Margaret L Gulley
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-10

3.  Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns.

Authors:  Alessandro Vanoli; Antonio Di Sabatino; Michele Martino; Catherine Klersy; Federica Grillo; Claudia Mescoli; Gabriella Nesi; Umberto Volta; Daniele Fornino; Ombretta Luinetti; Paolo Fociani; Vincenzo Villanacci; Francesco P D'Armiento; Renato Cannizzaro; Giovanni Latella; Carolina Ciacci; Livia Biancone; Marco Paulli; Fausto Sessa; Massimo Rugge; Roberto Fiocca; Gino R Corazza; Enrico Solcia
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

4.  Personalized therapy for pancreatic cancer: Myth or reality in 2010?

Authors:  Tzu-Chuan Jane Huang; Siddhartha Kar; Milind Javle
Journal:  J Gastrointest Oncol       Date:  2010-09

5.  Microsatellite instability and survival in gastric cancer: A systematic review and meta-analysis.

Authors:  Lin Zhu; Zhi Li; Yan Wang; Chenlu Zhang; Yunpeng Liu; Xiujuan Qu
Journal:  Mol Clin Oncol       Date:  2015-02-06

6.  Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.

Authors:  F Bataille; P Rümmele; W Dietmaier; D Gaag; F Klebl; A Reichle; P Wild; F Hofstädter; A Hartmann
Journal:  Mol Pathol       Date:  2003-10

7.  The gene-reduction effect of chromosomal losses detected in gastric cancers.

Authors:  Seung-Jin Hong; Eun-Jung Jeon; Jung-Hwan Oh; Eun-Joo Seo; Sang-Wook Choi; Mun-Gan Rhyu
Journal:  BMC Gastroenterol       Date:  2010-11-20       Impact factor: 3.067

8.  Stage IV early gastric cancer: two cases with microsatellite instability.

Authors:  Ji Yeong An; Min Gew Choi; Jae Hyung Noh; Kyoung-Mee Kim; Dae Sik Kim; Tae Sung Sohn; Sung Kim
Journal:  Langenbecks Arch Surg       Date:  2007-10-05       Impact factor: 3.445

9.  α3/4 Fucosyltransferase 3-dependent synthesis of Sialyl Lewis A on CD44 variant containing exon 6 mediates polymorphonuclear leukocyte detachment from intestinal epithelium during transepithelial migration.

Authors:  Jennifer C Brazil; Renpeng Liu; Ronen Sumagin; Keli N Kolegraff; Asma Nusrat; Richard D Cummings; Charles A Parkos; Nancy A Louis
Journal:  J Immunol       Date:  2013-09-25       Impact factor: 5.422

10.  A protein and mRNA expression-based classification of gastric cancer.

Authors:  Namrata Setia; Agoston T Agoston; Hye S Han; John T Mullen; Dan G Duda; Jeffrey W Clark; Vikram Deshpande; Mari Mino-Kenudson; Amitabh Srivastava; Jochen K Lennerz; Theodore S Hong; Eunice L Kwak; Gregory Y Lauwers
Journal:  Mod Pathol       Date:  2016-04-01       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.